Malignant neoplasm is a medical term for a cancerous tumour. It is a general term that includes many different types of cancer. These tumours can start anywhere in the body, and their specific type depends on the kinds of cells found inside them. Some common examples of malignant neoplasms include carcinomas, sarcomas, melanoma, and lymphomas.
A benign neoplasm is the opposite of a malignant neoplasm. Unlike malignant neoplasms, benign neoplasms are non-cancerous. The key difference is that the cells in a malignant neoplasm can spread to other parts of the body, a process called metastasis, whereas benign neoplasms cannot.
The word malignant comes from Latin roots meaning “badly born” or “harmful.” In medicine, it refers to a tumour made up of abnormal cells that grow uncontrollably, invade nearby tissues, and may spread through the blood or lymphatic system to other parts of the body.
This ability to invade and spread is what makes malignant tumours dangerous. In contrast, benign tumours grow more slowly, remain in one place, and do not invade surrounding tissues or metastasize.
Malignant neoplasms can start in almost any part of the body. The type of cancer depends on the tissue or cell of origin:
Carcinomas begin in epithelial cells, which line the surfaces of organs such as the skin, breast, colon, lungs, and prostate.
Sarcomas start in connective tissues such as bone, muscle, or fat.
Melanomas arise from melanocytes, the pigment-producing cells of the skin and other areas.
Lymphomas develop from lymphocytes, a type of white blood cell found in lymph nodes and other parts of the immune system.
Leukemias start in the bone marrow and involve abnormal growth of blood-forming cells.
Each type behaves differently and requires specific tests to diagnose and treat appropriately.
The diagnosis of a malignant neoplasm begins when a doctor removes a small piece of tissue through a biopsy or when a larger tumour is surgically removed. The tissue is sent to a pathologist, a doctor who examines cells and tissues under a microscope.
Pathologists look for specific features that indicate cancer, such as:
Abnormal cell size and shape.
Disorganized growth patterns.
Evidence of invasion into surrounding tissue.
Frequent cell division (mitotic activity).
If the features are consistent with cancer but the exact type of tumour is not yet clear, the pathologist may use the term malignant neoplasm as a preliminary diagnosis until additional tests are completed.
The term malignant neoplasm is often used as a preliminary diagnosis because it describes a cancerous tumour in general terms but does not specify the exact type of cancer. Pathologists may use this wording when only a small sample is available (such as a needle biopsy) or when additional tests are still pending.
A more specific diagnosis is usually made after all parts of the tumour have been examined, allowing the pathologist to determine its exact type and subtype.
Pathologists often perform additional tests on the biopsy sample to learn more about the tumour. These tests help identify the cancer type and may also provide information useful for treatment planning.
Common tests include:
Immunohistochemistry (IHC): This test uses special stains to detect proteins in the tumour cells that can indicate their origin or type.
Fluorescence in situ hybridization (FISH): Looks for specific genetic changes in the tumour cells.
In situ hybridization (ISH): Similar to FISH but may detect different genetic targets.
Next-generation sequencing (NGS): Examines many genes at once to identify mutations or other genetic alterations that may help guide targeted therapy.
These tests are especially helpful when the tumour has an unusual appearance or when the primary site of the cancer is unknown.
A more specific or final diagnosis can often be made after the entire tumour is removed and examined. This allows the pathologist to study all parts of the tumour and see patterns that may not be visible in a smaller biopsy. The final diagnosis includes details about the tumour’s type, grade, and stage — information that is essential for developing an effective treatment plan.
Cancer develops when genetic changes cause cells to grow and divide in an uncontrolled way. These changes can occur for many reasons, including:
Random errors during normal cell division.
Exposure to harmful substances such as tobacco, radiation, or certain chemicals.
Infections from viruses (such as human papillomavirus or hepatitis B).
Inherited genetic syndromes that increase cancer risk.
In many cases, there is no single identifiable cause.
Treatment depends on the tumour’s type, grade, stage, and location, as well as a person’s overall health.
Common treatment options include:
Surgery to remove the tumour.
Chemotherapy to kill rapidly dividing cells.
Radiation therapy to target cancer cells in a specific area.
Targeted therapy that focuses on specific genetic changes in the tumour.
Immunotherapy to boost the body’s immune system to fight cancer.
Your treatment plan is developed by your healthcare team, which may include oncologists, surgeons, and other specialists, based on the details in your pathology report.
The prognosis (expected outcome) depends on several factors, including the tumour’s type, size, location, grade, and stage, as well as whether it has spread to other parts of the body. Tumours that are small, low grade, and caught early generally have a better prognosis than those that are advanced or have metastasized.
Some malignant neoplasms, such as low grade carcinomas, tend to grow slowly and respond well to treatment. Others, such as high grade sarcomas or metastatic tumours, may behave more aggressively and require more intensive therapy.
Your pathology report provides essential information that helps your doctor predict how the tumour is likely to behave and choose the most appropriate treatment.
What type of malignant neoplasm do I have?
Has the cancer spread to other parts of my body?
What grade and stage is my tumour?
Were the surgical margins clear?
What additional tests are recommended?
What treatment options are available for my diagnosis?
What is my prognosis?
How often will I need follow-up tests or imaging?